Synthesis and In-vitro Phosphodiesterase 5 and 5A Inhibitory Activity of Novel 3-(3-thioxo-3h-1,2-dithiol-5-yl)phenyl4-[(1e)-3-oxo-3-phenylprop-1- en-1yl]benzoate and their Analogues

Author(s): Manish S. Bhatia, Amol S. Sherikar*, Rakesh P. Dhavale

Journal Name: Current Enzyme Inhibition

Volume 14 , Issue 2 , 2018

Become EABM
Become Reviewer

Graphical Abstract:


Introduction: 3-(3-thioxo-3H-1,2-dithiol-5-yl)phenyl 4-[(1E)-3-oxo-3-phenylprop-1-en-1- yl]benzoate and their analogues were synthesized on the basis of Claisen-Schmidt condensation reaction wherein chalcone intermediates were synthesized by the reaction of substituted aldehydes and acetophenones. Final products were synthesized by reacting chalcone intermediates with 5-(4- hydroxyphenyl)-3H-1,2-dithiole-3-thione.

Conclusion: The compounds were characterized by IR, 1H NMR, 13C NMR and elemental analysis. In in-vitro Phosphodiesterase 5 inhibitory activity, compounds G4 and G8 exhibited a significant inhibitory effect against human platelet Phosphodiesterase 5 (PDE 5) while compound G3 exhibited a significant inhibitory effect on both human platelet PDE 5 and bovine recombinant Phosphodiesterase 5A (PDE 5A). This work will be highly fruitful to design novel compounds for dealing with problems associated with vasculature.

Keywords: Bovine recombinant, claisen-schmidt, in-vitro, phosphodiesterase 5, vasculature, analogues.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2018
Published on: 05 July, 2018
Page: [85 - 91]
Pages: 7
DOI: 10.2174/1573408014666180406125124
Price: $65

Article Metrics

PDF: 26